Addendum

Brigatinib (non-small cell lung cancer) - Addendum to Commission A20-42

Status
Status: Commission completed
Project no.
G20-21
Last updated

Report documents

  1. Addendum

    Brigatinib (non-small cell lung cancer) - Addendum to Commission A20-42

    published on
    Document type
    PDF document, 173 kB, DE, not accessible

Project details

Project no.
G20-21
Commission
Commission awarded on 10.09.2020 by the Federal Joint Committee (GBA).
Report type
Addendum
Status
Commission completed
Department/Division
Health Economics
Topic
Cancer
Note

If the need for additional work on a project commissioned by the GBA arises during consultations, IQWiG submits an addendum. The subsequent decides on the extent of the added benefit concludes the early benefit assessment.

Connected Projects

  1. Dossier assessment

    Brigatinib (non-small cell lung cancer) - Benefit assessment according to §35a Social Code Book V

    Project no.
    A20-42
    Last updated

    Status: Commission completed

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form